Biotechnology company Intrexon has launched a new fundraising round aimed at bringing in $50 million in new investment. The DNA technologies company has raised $17 million in equity financing in the effort so far, according to securities filings. Last year, Intrexon closed a $100 million series E round of financing to expand its genetics technology. […]
Synthetic biotechnology company Intrexon — whose website is the descriptive www.dna.com — has raised $100 million that the company will use to expand its genetics technology. With the closing of its series E round of fundraising, Blacksburg, Virginia-based Intrexon has raised more than $259 million. The round was led by new, undisclosed investors. Existing investors […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.